Case Comprehensive Cancer Center

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Jul 7, 2026

Recruiting

Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Jul 7, 2026

Completed

Individualized Treatments in Adults With Relapsed/Refractory Cancers

Jul 2, 2026

Recruiting

Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors

Jul 2, 2026

Withdrawn

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

Earlier

Jun 27, 2026TrialPhase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Jun 27, 2026TrialNeoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

Jun 26, 2026TrialImpact of Tongue Proactive Strengthening Exercise Program on Speech and Swallowing Outcomes Following Partial/Hemiglossectomy and Reconstruction

Jun 26, 2026TrialTransanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS): A Pilot Randomized Controlled Trial

3 more events

Jun 26, 2026TrialThe Feasibility, Safety, and Clinical Outcomes of Fasting During Neoadjuvant Chemotherapy in Patients With Epithelial Ovarian Cancer

Jun 26, 2026TrialA Randomized Phase 2 Trial of Memory Avoidance Whole Brain Radiotherapy Versus Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

Jun 26, 2026TrialExploratory Analysis of the Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)